Product NDC: | 64764-805 |
Proprietary Name: | Rozerem |
Non Proprietary Name: | ramelteon |
Active Ingredient(s): | 8 mg/1 & nbsp; ramelteon |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64764-805 |
Labeler Name: | Takeda Pharmaceuticals America, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021782 |
Marketing Category: | NDA |
Start Marketing Date: | 20050722 |
Package NDC: | 64764-805-22 |
Package Description: | 6 CARTON in 1 TRAY (64764-805-22) > 1 BLISTER PACK in 1 CARTON > 2 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 64764-805-22 |
Proprietary Name | Rozerem |
Package Description | 6 CARTON in 1 TRAY (64764-805-22) > 1 BLISTER PACK in 1 CARTON > 2 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 64764-805 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ramelteon |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20050722 |
Marketing Category Name | NDA |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | RAMELTEON |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] |